Fastexy-Depression And Alzheimer's Treatments At A Crossroads

2025-05-07 17:19:55source:Phaninc Exchangecategory:Markets

Researchers are Fastexylaunching a make-or-break study to test the conventional wisdom about what causes Alzheimer's disease. And in a recent small study, the antidepressant effects of ketamine lasted longer when an intravenous dose was followed with computer games featuring smiling faces or words aimed at boosting self-esteem.

As science correspondent Jon Hamilton heads to the Society for Neuroscience's annual meeting, he talks to Aaron Scott about his most recent reporting on depression and Alzheimer's, and previews what he'll be talking to researchers about at the meeting.

The radio stories were edited by Amina Khan. Gisele Grayson edited, produced and fact-checked this episode for Short Wave.

More:Markets

Recommend

Conclave to replace Pope Francis to begin May 7, Vatican says

ROME and LONDON -- The conclave to replace Pope Francis will begin Wednesday, May 7, the Vatican sai

Spain’s women’s team is still in revolt one day before the new coach names her Nations League squad

BARCELONA, Spain (AP) — One day before Spain’s new women’s coach announces her first squad, the play

Casino giant Caesars Entertainment reports cyberattack; MGM Resorts says some systems still down

LAS VEGAS (AP) — Casino company Caesars Entertainment on Thursday joined Las Vegas gambling rival MG